Rigel Pharmaceuticals Inc

2026-10-15 19:56; UTC

Rigel Pharmaceuticals Inc is trading higher, rebounding after three sessions of declines, supported by strength in the broader biotechnology sector.

2026-10-14 21:31; UTC

Rigel Pharmaceuticals Inc is experiencing a significant decline in after-market trading, continuing a trend of four consecutive sessions finishing lower.

2026-10-13 19:16; UTC

Rigel Pharmaceuticals Inc shares fell, continuing a notable decline since Monday's close amid unusual activity, with prices around the middle of their one-month range.

2026-10-08 20:01; UTC

Rigel Pharmaceuticals Inc is trading higher, reaching a peak return after initial declines, currently above its 20-day moving average and near the upper end of its one-month range.

2026-10-07 20:01; UTC

Rigel Pharmaceuticals Inc is seeing a higher trading session today, marked by unusually high share volume, diverging from its recent upward trend since Tuesday.

2026-10-06 20:06; UTC

Rigel Pharmaceuticals Inc shares fell sharply, continuing a downward trend since Monday, with the price remaining well below its 20-day moving average.

2026-10-05 21:01; UTC

Rigel Pharmaceuticals Inc is trading lower in after-market hours, extending a decline that started at Monday's close amid a notably quiet session.

2026-10-01 20:07; UTC

Rigel Pharmaceuticals Inc shares fell sharply, closing significantly lower amid consistent pressure and a four-session losing streak below the 20-day moving average.

2026-09-24 20:07; UTC

Rigel Pharmaceuticals Inc shares fell, continuing a downward trend since Wednesday, despite a midday recovery, remaining below their opening level.

2026-09-23 20:07; UTC

Rigel Pharmaceuticals Inc shares fell sharply amid a declining broader market, reaching a low of nearly 3.75% below Tuesday's close before a slight recovery.

2026-09-18 20:02; UTC

Rigel Pharmaceuticals Inc is advancing today with unusually high trading activity, breaking from a recent trend of higher daily closes since Thursday.

2026-09-15 20:02; UTC

Rigel Pharmaceuticals is trading lower as the NY Empire State Manufacturing Index fell sharply, raising concerns about economic contraction in New York's manufacturing sector.

2026-09-11 19:46; UTC

Rigel Pharmaceuticals is higher today, influenced by CPI data and speculation about potential Federal Reserve interest rate hikes. The stock remains near its one-month trading range.

2026-09-10 23:21; UTC

Rigel Pharmaceuticals Inc is rising in after-market trading, reversing a three-session decline. No specific news was identified to explain this price action.

2026-09-08 20:07; UTC

Rigel Pharmaceuticals Inc shares are lower today, continuing a decline since Friday. The stock saw notable volatility but remains above its 20-day moving average.

2026-09-01 20:08; UTC

Rigel Pharmaceuticals Inc shares are higher today, reflecting strong market performance and robust momentum above the 20-day moving average. No specific news was identified.

2026-08-31 20:07; UTC

Rigel Pharmaceuticals is lower today as the market reacts to comments from Warsh at the Jackson Hole Economic Symposium regarding elevated inflation and potential rate hikes.

2026-08-25 20:07; UTC

Rigel Pharmaceuticals shares are advancing, supported by easing Treasury yields and lower oil prices, despite pulling back from earlier session highs.

2026-08-24 19:56; UTC

Rigel Pharmaceuticals Inc shares are lower today, with no specific news identified for the decline. The stock remains above its 20-day moving average.

2026-08-21 19:36; UTC

Rigel Pharmaceuticals Inc is trading higher, despite pulling back from an earlier session peak. The stock remains above its 20-day moving average.

2026-08-20 20:06; UTC

Rigel Pharmaceuticals Inc. shares are lower today, continuing a decline since Wednesday amid broader market pressures, though no specific news has been identified.

2026-08-19 20:02; UTC

Rigel Pharmaceuticals Inc is trading higher amid strong market activity and high volume, reflecting increased investor interest since Tuesday's close.

2026-08-18 22:01; UTC

Rigel Pharmaceuticals shares declined in after-market trading, dropping significantly amid broader market pressures from rising bond yields and inflation concerns.

2026-08-17 20:06; UTC

Rigel Pharmaceuticals Inc. shares declined despite mixed analyst ratings updates. Piper Sandler raised its price target to $49, while H.C. Wainwright set it at $85.

2026-08-14 20:06; UTC

HC Wainwright raised Rigel Pharmaceuticals' price target to $85, boosting investor sentiment. Shares are trading higher since Thursday's close amid mixed market conditions.

2026-08-13 19:16; UTC

Rigel Pharmaceuticals shares decline following the launch of its breast cancer drug Veppanu, priced at $29,400 per month, amid safety concerns.

2026-08-11 20:06; UTC

Rigel Pharmaceuticals Inc shares are higher in Tuesday's session, continuing gains from previous days amid routine fluctuations and no specific news driving the movement.

2026-08-07 19:26; UTC

Rigel Pharmaceuticals reported EPS of $0.88, exceeding estimates. Revenue of $78.70 million also surpassed expectations, though analysts have mixed ratings on the stock.

2026-08-06 20:06; UTC

Rigel Pharmaceuticals shares lower as the company in-licenses Veppanu for breast cancer treatment, projecting 2026 revenues of $285 million to $295 million.

2026-08-05 20:02; UTC

Rigel Pharmaceuticals shares rise as the company reports Q2 EPS of $0.88, exceeding estimates, and raises full-year sales guidance to $285 million-$295 million.